NYSE:IQVLife Sciences
A Look At IQVIA Holdings (IQV) Valuation After Charles River Deal And Fresh Analyst Coverage
IQVIA Holdings (IQV) is back on investors’ radar after fresh analyst coverage and a planned acquisition of discovery services assets from Charles River Laboratories. These moves directly target its clinical trial and data analytics footprint.
See our latest analysis for IQVIA Holdings.
Despite fresh interest around the Charles River deal and new analyst coverage, IQVIA’s share price has had a tough run, with a 30 day share price return of 10.95% and a year to date share price return of...